{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:55:25Z","timestamp":1790837725071,"version":"4.1.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Gout is an inflammatory arthritis mediated by monosodium urate deposition in synovial tissue. Colchicine is a common treatment for acute gout flares and prophylaxis, with well established efficacy but an incompletely understood mechanism. Investigating colchicine's impact at a proteomic and transcriptomic level may highlight these mechanisms. Interest in colchicine's effect on atherosclerotic cardiovascular disease (ASCVD) has stimulated additional research in this area.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Proteomic studies have helped identify gout's inflammatory signature, supporting prior evidence of nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 (NLRP3) inflammasome activation and involvement of inflammatory signaling pathways. Comparing recent \u2018omics studies between gout and colchicine use in ASCVD models reveals an overlap in inflammatory pathways. Colchicine reduced innate immune system activation in four separate ASCVD models, with notable overlap in mediators of the NLRP3 inflammasome [interleukin (IL)-1\u03b2, IL-6, IL-18, and monocyte chemotactic protein-1] and others.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Building on recent studies of colchicine's effect in ASCVD and the overlap seen with pathways implicated in gout, proteomic and transcriptomic studies in gout could further our understanding of the mechanisms driving colchicine's effectiveness. A more complete understanding of colchicine's mechanisms of action in gout may help guide future efforts at development of more targeted approaches to gout treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000001192","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:19:46Z","timestamp":1788949186000},"page":"401-411","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Colchicine-related effects on gene and protein expression in gout"],"prefix":"10.1097","volume":"38","author":[{"given":"Will T.","family":"Mitchell","sequence":"first","affiliation":[{"name":"University of Nebraska Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin M.","family":"Wheeler","sequence":"additional","affiliation":[{"name":"University of Nebraska Medical Center"},{"name":"VA Nebraska-Western Iowa Healthcare System, Omaha, Nebraska, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"issue":"(3s)","key":"R1-20261001","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.semarthrit.2020.04.008","article-title":"Gout epidemiology and comorbidities","volume":"50","author":"Singh","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"R2-20261001","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/art.40807","article-title":"Contemporary prevalence of gout and hyperuricemia in the united states and decadal trends: the National Health and Nutrition Examination Survey","volume":"71","author":"Chen-Xu","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R3-20261001","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/acr.24339","article-title":"Incidence, prevalence, and burden of gout in the veterans health administration","volume":"73","author":"Helget","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R4-20261001","doi-asserted-by":"crossref","first-page":"e239501","DOI":"10.1001\/jamanetworkopen.2023.9501","article-title":"Trends in prevalence of gout among US Asian adults","volume":"6","author":"Yokose","year":"2023","journal-title":"JAMA Netw Open"},{"key":"R5-20261001","first-page":"90","article-title":"The immunological basis in the pathogenesis of gout","volume":"14","author":"Chen","year":"2017","journal-title":"Iran J Immunol"},{"key":"R6-20261001","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jbspin.2018.06.011","article-title":"Association between gout and cardiovascular disease risk: a nation-wide case-control study","volume":"86","author":"Liang","year":"2019","journal-title":"Joint Bone Spine"},{"key":"R7-20261001","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.clinthera.2014.07.017","article-title":"Mechanism of action of colchicine in the treatment of gout","volume":"36","author":"Dalbeth","year":"2014","journal-title":"Clinical Therapeutics"},{"key":"R8-20261001","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.ard.2025.01.046","article-title":"Integrative analysis reveals the multilateral inflammatory mechanisms of CD14 monocytes in gout","volume":"84","author":"Alaswad","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"R9-20261001","doi-asserted-by":"crossref","first-page":"106180","DOI":"10.1016\/j.ejps.2022.106180","article-title":"Identification of potential biomarkers of gout through competitive endogenous RNA network analysis","volume":"173","author":"Li","year":"2022","journal-title":"Eur J Pharm Sci"},{"key":"R10-20261001","doi-asserted-by":"crossref","first-page":"1598835","DOI":"10.3389\/fgene.2025.1598835","article-title":"Integrative bioinformatics analysis and experimental validation reveals key genes and regulatory mechanisms in the development of gout","volume":"16","author":"Yuan","year":"2025","journal-title":"Front Genet"},{"key":"R11-20261001","doi-asserted-by":"crossref","first-page":"1367019","DOI":"10.3389\/fimmu.2024.1367019","article-title":"Identification of potential biomarkers of gout through weighted gene correlation network analysis","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"R12-20261001","doi-asserted-by":"crossref","first-page":"1468810","DOI":"10.3389\/fimmu.2024.1468810","article-title":"A targeted proteomics screen reveals serum and synovial fluid proteomic signature in patients with gout","volume":"15","author":"Huang","year":"2024","journal-title":"Front Immunol"},{"key":"R13-20261001","doi-asserted-by":"crossref","first-page":"107909","DOI":"10.1016\/j.isci.2023.107909","article-title":"Hyperuricemia remodels the serum proteome toward a higher inflammatory state","volume":"26","author":"Cab\u0103u","year":"2023","journal-title":"iScience"},{"key":"R14-20261001","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41584-019-0334-3","article-title":"Asymptomatic hyperuricaemia: a silent activator of the innate immune system","volume":"16","author":"Joosten","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"R15-20261001","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","article-title":"Understanding the physiology of FGF21","volume":"78","author":"Fisher","year":"2016","journal-title":"Annu Rev Physiol"},{"key":"R16-20261001","doi-asserted-by":"crossref","first-page":"686548","DOI":"10.3389\/fcell.2021.686548","article-title":"The roles of CCR9\/CCL25 in inflammation and inflammation-associated diseases","volume":"9","author":"Wu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R17-20261001","first-page":"keaf480","article-title":"Systemic inflammation in gout and the impact of treat-to-target urate-lowering therapy","author":"Wheeler","year":"2025","journal-title":"Rheumatology"},{"key":"R18-20261001","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100028","article-title":"Comparative effectiveness of allopurinol and febuxostat in gout management","volume":"1","author":"O\u2019Dell","year":"2022","journal-title":"NEJM Evid"},{"key":"R19-20261001","doi-asserted-by":"crossref","first-page":"24598","DOI":"10.1038\/s41598-024-74154-5","article-title":"Effective xanthine oxidase inhibitor urate lowering therapy in gout is linked to an emergent serum protein interactome of complement and inflammation modulators","volume":"14","author":"Sanchez","year":"2024","journal-title":"Sci Rep"},{"key":"R20-20261001","first-page":"945","article-title":"Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker","volume":"83","author":"Ea","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"R21-20261001","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"R22-20261001","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"R23-20261001","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa2405922","article-title":"Colchicine in acute myocardial infarction","volume":"392","author":"Jolly","year":"2025","journal-title":"N Engl J Med"},{"key":"R24-20261001","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"R25-20261001","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1042\/CS20160090","article-title":"Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation","volume":"130","author":"Robertson","year":"2016","journal-title":"Clin Sci (Lond)"},{"key":"R26-20261001","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2017.12.027","article-title":"The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation","volume":"269","author":"Mart\u00ednez","year":"2018","journal-title":"Atherosclerosis"},{"key":"R27-20261001","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/CIRCULATIONAHA.120.050560","article-title":"Colchicine attenuates inflammation beyond the inflammasome in chronic coronary artery disease: a LoDoCo2 Proteomic Substudy","volume":"142","author":"Opstal","year":"2020","journal-title":"Circulation"},{"key":"R28-20261001","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/clpt.1993.161","article-title":"Colchicine disposition in human leukocytes after single and multiple oral administration","volume":"54","author":"Chappey","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"R29-20261001","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/ATVBAHA.124.322252","article-title":"Colchicine inhibits smooth muscle cell phenotypic switch and aortic dissection in mice-brief report","volume":"45","author":"Jiang","year":"2025","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"(Pt B)","key":"R30-20261001","doi-asserted-by":"crossref","first-page":"107598","DOI":"10.1016\/j.intimp.2021.107598","article-title":"MCP-1: function, regulation, and involvement in disease","volume":"101","author":"Singh","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"R31-20261001","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1165\/ajrcmb.14.3.8845180","article-title":"Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane","volume":"14","author":"Delclaux","year":"1996","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R32-20261001","doi-asserted-by":"crossref","first-page":"119239","DOI":"10.1016\/j.atherosclerosis.2025.119239","article-title":"Experimental evidence on colchicine's mode of action in human carotid artery plaques","volume":"406","author":"von Ehr","year":"2025","journal-title":"Atherosclerosis"},{"key":"R33-20261001","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/CIRCRESAHA.120.315865","article-title":"S100A9 links inflammation and repair in myocardial infarction","volume":"127","author":"Marinkovi\u0107","year":"2020","journal-title":"Circ Res"},{"key":"R34-20261001","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092560","article-title":"The HSP90 family: structure, regulation, function, and implications in health and disease","volume":"19.","author":"Hoter","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R35-20261001","doi-asserted-by":"crossref","first-page":"157194","DOI":"10.1016\/j.phymed.2025.157194","article-title":"Colchicine alleviates atherosclerosis combined with diabetes mellitus by targeting PIM2 and regulating the NF-\u03baB signaling pathway","volume":"147","author":"Wang","year":"2025","journal-title":"Phytomedicine"},{"key":"R36-20261001","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1158\/0008-5472.CAN-21-3899","article-title":"PIM2 expression induced by proinflammatory macrophages suppresses immunotherapy efficacy in hepatocellular carcinoma","volume":"82","author":"Wang","year":"2022","journal-title":"Cancer Res"},{"key":"R37-20261001","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2567.2010.03286.x","article-title":"Proviral integration site 2 is required for interleukin-6 expression induced by interleukin-1, tumour necrosis factor-\u03b1 and lipopolysaccharide","volume":"131","author":"Yang","year":"2010","journal-title":"Immunology"},{"key":"R38-20261001","article-title":"The effect of prophylactic colchicine use on gene expression in gout [abstract]","volume":"77","author":"Wheeler","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"R39-20261001","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1074\/mcp.M114.047480","article-title":"Integrated bottom-up and top-down proteomics of patient-derived breast tumor xenografts","volume":"15","author":"Ntai","year":"2016","journal-title":"Mol Cell Proteomics"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0000000000001192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:02:26Z","timestamp":1790834546000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0000000000001192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000001192","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]}}}